Tube packaging occupies a unique position within the broader landscape of primary packaging formats. Unlike rigid containers — glass vials, HDPE bottles or aluminium canisters — the tube combines flexible dispensing mechanics with precise dose control, product protection and direct surface contact with the formulation throughout the entire period of use. These characteristics make tubes the packaging format of choice for a broad spectrum of product categories: topical pharmaceutical preparations (creams, gels, ointments, emulsions), dermocosmetic formulations, oral care products, ophthalmic gels and wound care preparations.
From a regulatory standpoint, the tube constitutes a primary packaging component subject to full compliance requirements under Directive 2001/83/EC for medicinal products and under the EU Cosmetic Products Regulation (EC) No 1223/2009 for cosmetic formulations. In both regulatory frameworks, the manufacturer is required to demonstrate compatibility between the packaging material and the enclosed product — a requirement that goes far beyond simple chemical inertness and encompasses extractables and leachables profiling, barrier performance under accelerated ageing conditions and functional integrity of the closure system throughout the declared shelf life.
Material Architecture of Cosmetic and Pharmaceutical Tubes — From Monolayer to Co-Extruded Barrier Structures
The material composition of a tube body determines its functional performance profile across several critical parameters: chemical resistance to the formulation, oxygen and moisture barrier properties, mechanical flexibility and recoverability after squeezing, as well as end-of-life recyclability.
Monolayer polyethylene tubes — manufactured from LDPE, LLDPE or HDPE — represent the most widely used format in both cosmetic and pharmaceutical applications. LDPE offers superior flexibility and tactile softness, making it the preferred choice for formulations dispensed in small incremental doses. HDPE provides greater stiffness and chemical resistance, suitable for products with higher solvent content or aggressive active ingredients. Monolayer PE tubes are fully recyclable within the polyethylene stream and compatible with PCR (post-consumer recycled) content incorporation at levels up to 100% without significant loss of mechanical properties.
Co-extruded multilayer tubes (CO-EX) incorporate between two and five layers of distinct polymers, enabling independent optimisation of surface aesthetics, structural integrity and barrier performance within a single tube wall. The most functionally significant layer in pharmaceutical-grade co-extruded tubes is the EVOH (ethylene vinyl alcohol copolymer) barrier layer, positioned centrally within the wall structure. EVOH exhibits an oxygen transmission rate (OTR) of 0.01–0.10 cm³·mm/m²·day·atm — several orders of magnitude lower than standard polyethylene — making co-extruded tubes with EVOH the standard choice for oxygen-sensitive formulations: retinoids, unsaturated fatty acid-based preparations, benzoyl peroxide gels and products containing unstable botanical extracts.
Sugarcane bio-PE tubes — produced from bioethanol-derived polyethylene (bio-HDPE or bio-LDPE) sourced from Brazilian sugarcane — offer an identical mechanical and chemical performance profile to fossil-based PE whilst delivering a significantly reduced carbon footprint. Life cycle assessments (LCA per ISO 14040/14044) consistently demonstrate a net CO₂ reduction of 2.15 kg CO₂ equivalent per kilogram of bio-PE compared to virgin fossil PE, qualifying sugarcane tubes as a credible sustainability claim vehicle under current EU Green Claims Directive proposals.
GMP Compliance and Quality System Requirements for Pharmaceutical Tube Manufacturing
Pharmaceutical tube packaging manufactured for use as primary containers for medicinal products must be produced under a certified GMP (Good Manufacturing Practice) quality system compliant with EU GMP Annex 1 (sterile products) or equivalent chapter requirements for non-sterile topical preparations. GMP certification for packaging component manufacturers, whilst not universally mandatory across all EU markets, is increasingly required by pharmaceutical MAHs (Marketing Authorisation Holders) as a contractual supply chain condition and is explicitly expected within the framework of ICH Q10 pharmaceutical quality system guidelines.
Key GMP requirements applicable to tube manufacturing operations include: environmental monitoring and controlled area classification for filling and sealing operations, validated cleaning procedures for production equipment, in-process control procedures covering dimensional verification (diameter, wall thickness, shoulder geometry), closure torque or snap-fit force measurement, leak testing (100% or statistical sampling per AQL level II), and visual inspection using automated optical systems for surface defect detection.
Cosmetic and pharmaceutical tube packaging produced under ISO 9001 and GMP certification frameworks provides MAHs and cosmetic brands with the documented supplier qualification evidence required by both regulatory agencies and internal quality assurance procedures, significantly reducing the qualification burden for new packaging components.
Decoration, Closure Systems and Functional Differentiation in Tube Packaging
The decoration of cosmetic and pharmaceutical tubes serves both brand communication and regulatory compliance functions. Pharmaceutical tubes must carry mandatory labelling elements as specified in Article 54 of Directive 2001/83/EC — INN (international non-proprietary name), strength, pharmaceutical form, route of administration, expiry date and batch number — all printed with sufficient contrast and font size to comply with the QRD (Quality Review of Documents) template requirements.
Cosmetic tube decoration leverages the full range of available printing technologies: screen printing (up to 6 colours), flexographic printing, offset printing (up to 9 colours) and combination flexo-screen processes (up to 8 colours), supplemented by finish effects including soft-touch varnish, hot stamping and cold stamping. Closure systems range from standard screw caps in PE or PP to flip-top closures, octagonal caps and first-opening guarantee membranes — a feature increasingly required for both cosmetic and OTC pharmaceutical products in the context of tamper-evidence regulations.
